IKT
Inhibikase Therapeutics Inc
Price:
2.01
USD
Volume:
156,955
United States | Biotechnology
IKT Net Margin
As of 2025-07-09, the Net Margin of Inhibikase Therapeutics Inc (IKT) is -7304.7%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
IKT Net Margin - Historical Value
| Date | Value |
|---|---|
| 2024-12-31 | -7304.7% |
| 2023-12-31 | -7304.8% |
| 2022-12-31 | -15041.7% |
| 2021-12-31 | -477.1% |
| 2020-12-31 | -407.1% |
| 2019-12-31 | -510.7% |
| 2018-12-31 | -53.2% |
| 2017-12-31 | -21.4% |
| 2016-12-31 | -64.9% |
| - |
IKT Net Margin - Peers Comparison